Selected research
Market Analysis & Forecast
Global Oral Bordetella Vaccine Market Analysis and Forecast 2026-2032
Market perspective
The global Oral Bordetella Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Bordetella Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Oral Bordetella Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Oral Bordetella Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Oral Bordetella Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Oral Bordetella Vaccine include Zoetis, Merck Animal Health, Boehringer Ingelheim(Merial) and Elanco, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Bordetella Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Oral Bordetella Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Bordetella Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Bordetella Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Bordetella Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Bordetella Vaccine sales, projected growth trends, production technology, application and end-user industry.
Oral Bordetella Vaccine Segment by Company
Zoetis
Merck Animal Health
Boehringer Ingelheim(Merial)
Elanco
Oral Bordetella Vaccine Segment by Type
Combination Vaccine
Only Bordetella Vaccine
Oral Bordetella Vaccine Segment by Application
Puppies
Adult Dogs
Oral Bordetella Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Bordetella Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Bordetella Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Bordetella Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oral Bordetella Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oral Bordetella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Bordetella Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Combination Vaccine
- Only Bordetella Vaccine
Applications
- Puppies
- Adult Dogs
Companies covered
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim(Merial)
- Elanco
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Oral Bordetella Vaccine Market by Type
- 1.2.1 Global Oral Bordetella Vaccine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Combination Vaccine
- 1.2.3 Only Bordetella Vaccine
- 1.3 Oral Bordetella Vaccine Market by Application
- 1.3.1 Global Oral Bordetella Vaccine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Puppies
- 1.3.3 Adult Dogs
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Oral Bordetella Vaccine Market Dynamics
- 2.1 Oral Bordetella Vaccine Industry Trends
- 2.2 Oral Bordetella Vaccine Industry Drivers
- 2.3 Oral Bordetella Vaccine Industry Opportunities and Challenges
- 2.4 Oral Bordetella Vaccine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Oral Bordetella Vaccine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Oral Bordetella Vaccine Revenue by Region
- 3.2.1 Global Oral Bordetella Vaccine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Oral Bordetella Vaccine Revenue by Region (2021-2026)
- 3.2.3 Global Oral Bordetella Vaccine Revenue by Region (2027-2032)
- 3.2.4 Global Oral Bordetella Vaccine Revenue Market Share by Region (2021-2032)
- 3.3 Global Oral Bordetella Vaccine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Oral Bordetella Vaccine Sales by Region
- 3.4.1 Global Oral Bordetella Vaccine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Oral Bordetella Vaccine Sales by Region (2021-2026)
- 3.4.3 Global Oral Bordetella Vaccine Sales by Region (2027-2032)
- 3.4.4 Global Oral Bordetella Vaccine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Oral Bordetella Vaccine Revenue by Manufacturers
- 4.1.1 Global Oral Bordetella Vaccine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Oral Bordetella Vaccine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Oral Bordetella Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Oral Bordetella Vaccine Sales by Manufacturers
- 4.2.1 Global Oral Bordetella Vaccine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Oral Bordetella Vaccine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Oral Bordetella Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Oral Bordetella Vaccine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Oral Bordetella Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Oral Bordetella Vaccine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Oral Bordetella Vaccine Manufacturers, Product Type & Application
- 4.7 Global Oral Bordetella Vaccine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Oral Bordetella Vaccine Market CR5 and HHI
- 4.8.2 2025 Oral Bordetella Vaccine Tier 1, Tier 2, and Tier 3
5 Oral Bordetella Vaccine Market by Type
- 5.1 Global Oral Bordetella Vaccine Revenue by Type
- 5.1.1 Global Oral Bordetella Vaccine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Oral Bordetella Vaccine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Oral Bordetella Vaccine Revenue Market Share by Type (2021-2032)
- 5.2 Global Oral Bordetella Vaccine Sales by Type
- 5.2.1 Global Oral Bordetella Vaccine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Oral Bordetella Vaccine Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Oral Bordetella Vaccine Sales Market Share by Type (2021-2032)
- 5.3 Global Oral Bordetella Vaccine Price by Type
6 Oral Bordetella Vaccine Market by Application
- 6.1 Global Oral Bordetella Vaccine Revenue by Application
- 6.1.1 Global Oral Bordetella Vaccine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Oral Bordetella Vaccine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Oral Bordetella Vaccine Revenue Market Share by Application (2021-2032)
- 6.2 Global Oral Bordetella Vaccine Sales by Application
- 6.2.1 Global Oral Bordetella Vaccine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Oral Bordetella Vaccine Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Oral Bordetella Vaccine Sales Market Share by Application (2021-2032)
- 6.3 Global Oral Bordetella Vaccine Price by Application
7 Company Profiles
- 7.1 Zoetis
- 7.1.1 Zoetis Company Information
- 7.1.2 Zoetis Business Overview
- 7.1.3 Zoetis Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Zoetis Oral Bordetella Vaccine Product Portfolio
- 7.1.5 Zoetis Recent Developments
- 7.2 Merck Animal Health
- 7.2.1 Merck Animal Health Company Information
- 7.2.2 Merck Animal Health Business Overview
- 7.2.3 Merck Animal Health Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Merck Animal Health Oral Bordetella Vaccine Product Portfolio
- 7.2.5 Merck Animal Health Recent Developments
- 7.3 Boehringer Ingelheim(Merial)
- 7.3.1 Boehringer Ingelheim(Merial) Company Information
- 7.3.2 Boehringer Ingelheim(Merial) Business Overview
- 7.3.3 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Portfolio
- 7.3.5 Boehringer Ingelheim(Merial) Recent Developments
- 7.4 Elanco
- 7.4.1 Elanco Company Information
- 7.4.2 Elanco Business Overview
- 7.4.3 Elanco Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Elanco Oral Bordetella Vaccine Product Portfolio
- 7.4.5 Elanco Recent Developments
8 North America
- 8.1 North America Oral Bordetella Vaccine Market Size by Type
- 8.1.1 North America Oral Bordetella Vaccine Revenue by Type (2021-2032)
- 8.1.2 North America Oral Bordetella Vaccine Sales by Type (2021-2032)
- 8.1.3 North America Oral Bordetella Vaccine Price by Type (2021-2032)
- 8.2 North America Oral Bordetella Vaccine Market Size by Application
- 8.2.1 North America Oral Bordetella Vaccine Revenue by Application (2021-2032)
- 8.2.2 North America Oral Bordetella Vaccine Sales by Application (2021-2032)
- 8.2.3 North America Oral Bordetella Vaccine Price by Application (2021-2032)
- 8.3 North America Oral Bordetella Vaccine Market Size by Country
- 8.3.1 North America Oral Bordetella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Oral Bordetella Vaccine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Oral Bordetella Vaccine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Oral Bordetella Vaccine Market Size by Type
- 9.1.1 Europe Oral Bordetella Vaccine Revenue by Type (2021-2032)
- 9.1.2 Europe Oral Bordetella Vaccine Sales by Type (2021-2032)
- 9.1.3 Europe Oral Bordetella Vaccine Price by Type (2021-2032)
- 9.2 Europe Oral Bordetella Vaccine Market Size by Application
- 9.2.1 Europe Oral Bordetella Vaccine Revenue by Application (2021-2032)
- 9.2.2 Europe Oral Bordetella Vaccine Sales by Application (2021-2032)
- 9.2.3 Europe Oral Bordetella Vaccine Price by Application (2021-2032)
- 9.3 Europe Oral Bordetella Vaccine Market Size by Country
- 9.3.1 Europe Oral Bordetella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Oral Bordetella Vaccine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Oral Bordetella Vaccine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Oral Bordetella Vaccine Market Size by Type
- 10.1.1 China Oral Bordetella Vaccine Revenue by Type (2021-2032)
- 10.1.2 China Oral Bordetella Vaccine Sales by Type (2021-2032)
- 10.1.3 China Oral Bordetella Vaccine Price by Type (2021-2032)
- 10.2 China Oral Bordetella Vaccine Market Size by Application
- 10.2.1 China Oral Bordetella Vaccine Revenue by Application (2021-2032)
- 10.2.2 China Oral Bordetella Vaccine Sales by Application (2021-2032)
- 10.2.3 China Oral Bordetella Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Oral Bordetella Vaccine Market Size by Type
- 11.1.1 Asia Oral Bordetella Vaccine Revenue by Type (2021-2032)
- 11.1.2 Asia Oral Bordetella Vaccine Sales by Type (2021-2032)
- 11.1.3 Asia Oral Bordetella Vaccine Price by Type (2021-2032)
- 11.2 Asia Oral Bordetella Vaccine Market Size by Application
- 11.2.1 Asia Oral Bordetella Vaccine Revenue by Application (2021-2032)
- 11.2.2 Asia Oral Bordetella Vaccine Sales by Application (2021-2032)
- 11.2.3 Asia Oral Bordetella Vaccine Price by Application (2021-2032)
- 11.3 Asia Oral Bordetella Vaccine Market Size by Country
- 11.3.1 Asia Oral Bordetella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Oral Bordetella Vaccine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Oral Bordetella Vaccine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Oral Bordetella Vaccine Market Size by Type
- 12.1.1 SAMEA Oral Bordetella Vaccine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Oral Bordetella Vaccine Sales by Type (2021-2032)
- 12.1.3 SAMEA Oral Bordetella Vaccine Price by Type (2021-2032)
- 12.2 SAMEA Oral Bordetella Vaccine Market Size by Application
- 12.2.1 SAMEA Oral Bordetella Vaccine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Oral Bordetella Vaccine Sales by Application (2021-2032)
- 12.2.3 SAMEA Oral Bordetella Vaccine Price by Application (2021-2032)
- 12.3 SAMEA Oral Bordetella Vaccine Market Size by Country
- 12.3.1 SAMEA Oral Bordetella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Oral Bordetella Vaccine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Oral Bordetella Vaccine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Oral Bordetella Vaccine Value Chain Analysis
- 13.1.1 Oral Bordetella Vaccine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Oral Bordetella Vaccine Production Mode & Process
- 13.2 Oral Bordetella Vaccine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Oral Bordetella Vaccine Distributors
- 13.2.3 Oral Bordetella Vaccine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst